Deutsche Bank Aktiengesellschaft Downgrades Merck & Co., Inc. (NYSE:MRK) to Hold

Deutsche Bank Aktiengesellschaft lowered shares of Merck & Co., Inc. (NYSE:MRK – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday morning, MarketBeat reports. They currently have $105.00 target price on the stock, down from their prior target price of $128.00. MRK has been the subject […]

Leave a Reply

Your email address will not be published.

Previous post Wolfe Research Initiates Coverage on Shoals Technologies Group (NASDAQ:SHLS)
Next post China new models January 2025: BYD Xia and Hongqi Guoli arrive